A detailed history of Altfest L J & CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, Altfest L J & CO Inc holds 41,071 shares of PFE stock, worth $1.09 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
41,071
Previous 42,208 2.69%
Holding current value
$1.09 Million
Previous $1.18 Million 0.68%
% of portfolio
0.16%
Previous 0.16%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$27.7 - $31.39 $31,494 - $35,690
-1,137 Reduced 2.69%
41,071 $1.19 Million
Q2 2024

Aug 07, 2024

BUY
$25.26 - $29.6 $15,686 - $18,381
621 Added 1.49%
42,208 $1.18 Million
Q1 2024

Apr 22, 2024

SELL
$25.89 - $29.73 $84,297 - $96,800
-3,256 Reduced 7.26%
41,587 $1.15 Million
Q4 2023

Jan 18, 2024

BUY
$26.13 - $33.94 $89,364 - $116,074
3,420 Added 8.26%
44,843 $1.29 Million
Q3 2023

Oct 26, 2023

SELL
$32.09 - $37.51 $375,067 - $438,416
-11,688 Reduced 22.01%
41,423 $1.37 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $428,310 - $495,545
11,858 Added 28.74%
53,111 $1.95 Million
Q1 2023

Apr 20, 2023

SELL
$39.39 - $51.28 $15,243 - $19,845
-387 Reduced 0.93%
41,253 $1.68 Million
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $4,717 - $6,158
113 Added 0.27%
41,640 $2.13 Million
Q3 2022

Nov 15, 2022

BUY
$43.76 - $53.42 $16,147 - $19,711
369 Added 0.9%
41,527 $1.82 Million
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $30,570 - $36,246
657 Added 1.62%
41,158 $2.16 Million
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $65,422 - $81,066
-1,430 Reduced 3.41%
40,501 $2.1 Million
Q4 2021

Jan 24, 2022

SELL
$41.32 - $61.25 $572,943 - $849,292
-13,866 Reduced 24.85%
41,931 $2.48 Million
Q3 2021

Oct 12, 2021

BUY
$39.25 - $50.42 $421,309 - $541,208
10,734 Added 23.82%
55,797 $2.4 Million
Q2 2021

Jul 28, 2021

SELL
$35.91 - $40.68 $56,917 - $64,477
-1,585 Reduced 3.4%
45,063 $1.77 Million
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $48,794 - $55,030
1,457 Added 3.22%
46,648 $1.69 Million
Q4 2020

Jan 21, 2021

SELL
$33.47 - $42.56 $120,056 - $152,662
-3,587 Reduced 7.35%
45,191 $1.66 Million
Q3 2020

Oct 29, 2020

SELL
$31.75 - $37.25 $967,295 - $1.13 Million
-30,466 Reduced 38.45%
48,778 $1.79 Million
Q2 2020

Jul 21, 2020

BUY
$30.12 - $36.54 $384,993 - $467,054
12,782 Added 19.23%
79,244 $2.59 Million
Q1 2020

Apr 13, 2020

BUY
$27.03 - $38.62 $83,684 - $119,567
3,096 Added 4.89%
66,462 $2.17 Million
Q4 2019

Jan 06, 2020

BUY
$32.92 - $37.36 $194,590 - $220,834
5,911 Added 10.29%
63,366 $2.48 Million
Q3 2019

Oct 10, 2019

BUY
$32.49 - $42.13 $275,742 - $357,557
8,487 Added 17.33%
57,455 $2.06 Million
Q2 2019

Jul 15, 2019

SELL
$36.98 - $41.52 $536,394 - $602,247
-14,505 Reduced 22.85%
48,968 $2.12 Million
Q1 2019

Jun 10, 2019

SELL
$37.5 - $41.2 $412,537 - $453,241
-11,001 Reduced 14.77%
63,473 $2.7 Million
Q1 2019

May 24, 2019

SELL
$37.5 - $41.2 $5.28 Million - $5.8 Million
-140,689 Reduced 65.39%
74,474 $3.25 Million
Q1 2019

Apr 05, 2019

BUY
$37.5 - $41.2 $5.27 Million - $5.79 Million
140,641 Added 188.72%
215,163 $3.6 Million
Q4 2018

Jan 15, 2019

SELL
$38.47 - $43.86 $86,095 - $98,158
-2,238 Reduced 2.92%
74,522 $3.25 Million
Q3 2018

Oct 10, 2018

SELL
$34.47 - $41.81 $124,850 - $151,435
-3,622 Reduced 4.51%
76,760 $3.38 Million
Q2 2018

Aug 07, 2018

SELL
$32.98 - $35.16 $225,847 - $240,775
-6,848 Reduced 7.85%
80,382 $2.92 Million
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $52,747 - $61,194
1,653 Added 1.93%
87,230 $3.1 Million
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $663,137 - $703,612
-19,938 Reduced 18.9%
85,577 $3.1 Million
Q3 2017

Oct 23, 2017

BUY
$31.0 - $34.15 $3.27 Million - $3.6 Million
105,515
105,515 $3.77 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Altfest L J & CO Inc Portfolio

Follow Altfest L J & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.